4/16
08:39 am
vxrt
Vaxartto Present at World Vaccine Congress Washington 2025 on April 23 [Yahoo! Finance]
Medium
Report
Vaxartto Present at World Vaccine Congress Washington 2025 on April 23 [Yahoo! Finance]
4/16
08:00 am
vxrt
Vaxartto Present at World Vaccine Congress Washington 2025 on April 23
Medium
Report
Vaxartto Present at World Vaccine Congress Washington 2025 on April 23
3/31
07:59 pm
vxrt
RFK Jr.'s layoffs expected to gut worker safety agency NIOSH, officials say [CBS News]
Medium
Report
RFK Jr.'s layoffs expected to gut worker safety agency NIOSH, officials say [CBS News]
3/27
01:22 pm
vxrt
Vaxart, Inc. (NASDAQ: VXRT) had its price target lowered by analysts at B. Riley from $2.50 to $2.00. They now have a "buy" rating on the stock.
Low
Report
Vaxart, Inc. (NASDAQ: VXRT) had its price target lowered by analysts at B. Riley from $2.50 to $2.00. They now have a "buy" rating on the stock.
3/27
08:00 am
vxrt
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/20
04:01 pm
vxrt
Vaxart Provides Business Update and Reports Full Year 2024 Financial Results
High
Report
Vaxart Provides Business Update and Reports Full Year 2024 Financial Results
3/13
08:00 am
vxrt
Vaxart to Host Full Year 2024 Business Update and Financial Results Conference Call on March 20
Medium
Report
Vaxart to Host Full Year 2024 Business Update and Financial Results Conference Call on March 20
3/11
08:00 am
vxrt
Vaxart Announces Clinical Trial Initiation of Norovirus Oral Pill Vaccine Candidate
Low
Report
Vaxart Announces Clinical Trial Initiation of Norovirus Oral Pill Vaccine Candidate
3/5
07:06 pm
vxrt
Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults [Yahoo! Finance]
Medium
Report
Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults [Yahoo! Finance]
3/5
04:05 pm
vxrt
Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults
Low
Report
Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults
2/25
05:40 pm
vxrt
Multimillion-dollar Biden-era COVID-19 vax project halted by Trump's HHS [FOX News]
Low
Report
Multimillion-dollar Biden-era COVID-19 vax project halted by Trump's HHS [FOX News]
1/28
08:00 am
vxrt
Vaxart Appoints Seasoned Biotech Executive Kevin Finney to Board of Directors
Low
Report
Vaxart Appoints Seasoned Biotech Executive Kevin Finney to Board of Directors